Prolactinomas.
作者信息
Grossman A, Besser G M
出版信息
Br Med J (Clin Res Ed). 1985 Jan 19;290(6463):182-4. doi: 10.1136/bmj.290.6463.182.
Abstract
摘要
相似文献
1
Prolactinomas.催乳素瘤
Br Med J (Clin Res Ed). 1985 Jan 19;290(6463):182-4. doi: 10.1136/bmj.290.6463.182.
2
Prolactinomas in women: current therapies.
Ann Intern Med. 1983 Jul;99(1):115-8. doi: 10.7326/0003-4819-99-1-115.
3
Long term suppression of prolactin concentrations after bromocriptine induced regression of pituitary prolactinomas.溴隐亭诱导垂体泌乳素瘤消退后泌乳素浓度的长期抑制。
Br Med J (Clin Res Ed). 1985 Jan 12;290(6462):117-8. doi: 10.1136/bmj.290.6462.117-a.
4
Relationship between the methods of treatment for prolactinomas and the puerperal lactation.催乳素瘤治疗方法与产后泌乳之间的关系。
Fertil Steril. 1987 May;47(5):867-9. doi: 10.1016/s0015-0282(16)59182-1.
5
Bromocriptine: Does it jeopardise the result of later surgery for prolactinomas?溴隐亭：它会影响催乳素瘤后续手术的结果吗？
Lancet. 1982 Sep 18;2(8299):657-8. doi: 10.1016/s0140-6736(82)92756-8.
6
Conservative management of pituitary prolactinomas; evidence for bromocriptine-induced regression.
Br J Obstet Gynaecol. 1980 Jun;87(6):523-9. doi: 10.1111/j.1471-0528.1980.tb04590.x.
7
Pregnancy after combined treatment with bromocriptine and tamoxifen in two patients with pituitary prolactinomas.
Fertil Steril. 1986 Aug;46(2):312-4. doi: 10.1016/s0015-0282(16)49531-2.
8
To treat or not to treat: hyperprolactinemia.治疗还是不治疗：高催乳素血症。
JAMA. 1982 Aug 6;248(5):515-6. doi: 10.1001/jama.1982.03330050005003.
9
[Evaluation of the elution pattern of the serum and CSF prolactin fractionated by gel filtration chromatography in cases of bromocriptine-resistant prolactinoma].[溴隐亭抵抗性催乳素瘤患者血清和脑脊液中经凝胶过滤色谱法分离的催乳素洗脱模式的评估]
Neurol Med Chir (Tokyo). 1987 Mar;27(3):195-201. doi: 10.2176/nmc.27.195.
10
Bromocriptine treatment of prolactin-secreting tumors: surgical implications.溴隐亭治疗催乳素分泌性肿瘤：手术意义
Neurosurgery. 1983 Jun;12(6):640-2. doi: 10.1227/00006123-198306000-00008.
引用本文的文献
1
Hypopituitarism patterns and prevalence among men with macroprolactinomas.大泌乳素瘤男性患者的垂体功能减退模式及患病率
Pituitary. 2015 Feb;18(1):108-15. doi: 10.1007/s11102-014-0563-z.
2
The pituitary stalk effect: is it a passing phenomenon?垂体柄效应：它是一种短暂现象吗？
J Neurooncol. 2014 May;117(3):477-84. doi: 10.1007/s11060-014-1386-5. Epub 2014 Feb 19.
3
Hyperprolactinemia in Women of Reproductive Age: Etiology, diagnosis, and management.育龄期女性高催乳素血症：病因、诊断与管理
Can Fam Physician. 1992 Feb;38:367-79.
4
Long-term efficacy of bromocriptine in macroprolactinomas and giant prolactinomas in men.溴隐亭治疗男性大泌乳素瘤和巨大泌乳素瘤的长期疗效。
Pituitary. 2005;8(2):147-54. doi: 10.1007/s11102-005-5111-4.
5
The role of hormones, growth factors and their receptors in pituitary tumorigenesis.激素、生长因子及其受体在垂体肿瘤发生中的作用。
Brain Pathol. 2001 Jul;11(3):356-70. doi: 10.1111/j.1750-3639.2001.tb00405.x.
6
A prolactin-secreting tumor in a patient with Klinefelter's syndrome: a case report.克兰费尔特综合征患者的催乳素分泌瘤：一例报告
J Endocrinol Invest. 1996 Apr;19(4):248-52. doi: 10.1007/BF03349876.
7
Diagnosis and drug therapy of prolactinoma.泌乳素瘤的诊断与药物治疗
Drugs. 1996 Jun;51(6):954-65. doi: 10.2165/00003495-199651060-00004.
8
Management of selected patients with hyperprolactinaemia by partial hypophysectomy.部分垂体切除术治疗部分高催乳素血症患者
Br Med J (Clin Res Ed). 1985 Nov 30;291(6508):1547-50. doi: 10.1136/bmj.291.6508.1547.
9
Reversal of severe osteopenia in a patient with hyperprolactinemia treated with bromocriptine.用溴隐亭治疗的高泌乳素血症患者严重骨质减少的逆转。
West J Med. 1988 Sep;149(3):341-3.
10
Hyperprolactinaemia.高催乳素血症
BMJ. 1988 Nov 12;297(6658):1268. doi: 10.1136/bmj.297.6658.1268-c.
本文引用的文献
1
Microadenomas of the pituitary and abnormal sellar tomograms in an unselected autopsy series.在一个未经筛选的尸检系列中垂体微腺瘤和蝶鞍断层扫描异常情况
N Engl J Med. 1981 Jan 15;304(3):156-8. doi: 10.1056/NEJM198101153040306.
2
Decreased bone density in hyperprolactinemic women.高泌乳素血症女性的骨密度降低。
N Engl J Med. 1980 Dec 25;303(26):1511-4. doi: 10.1056/NEJM198012253032605.
3
Evidence for an increased opioid inhibition of luteinizing hormone secretion in hyperprolactinemic patients with pituitary microadenoma.垂体微腺瘤所致高泌乳素血症患者中阿片类物质对促黄体生成素分泌抑制作用增强的证据。
J Clin Endocrinol Metab. 1980 Mar;50(3):427-30. doi: 10.1210/jcem-50-3-427.
4
Size reduction of macroprolactinomas by bromocriptine or lisuride treatment.溴隐亭或利舒脲治疗对大泌乳素瘤的缩瘤作用。
J Clin Endocrinol Metab. 1981 Oct;53(4):737-43. doi: 10.1210/jcem-53-4-737.
5
Rapid changes of prolactinoma volume after withdrawal and reinstitution of bromocriptine.停用和重新使用溴隐亭后泌乳素瘤体积的快速变化。
J Clin Endocrinol Metab. 1981 Sep;53(3):480-3. doi: 10.1210/jcem-53-3-480.
6
Spontaneous development of hyperprolactinaemia.高泌乳素血症的自发发展。
Acta Endocrinol (Copenh). 1982 Jul;100(3):333-6. doi: 10.1530/acta.0.1000333.
7
Menstrual function and serum prolactin levels after long-term bromocriptine treatment of hyperprolactinaemic amenorrhoea.高泌乳素血症性闭经长期使用溴隐亭治疗后的月经功能及血清泌乳素水平
Clin Endocrinol (Oxf). 1982 Jun;16(6):587-93. doi: 10.1111/j.1365-2265.1982.tb03175.x.
8
Regions of low density in the contrast-enhanced pituitary gland: normal and pathologic processes.增强扫描垂体中的低密度区：正常及病理过程
Radiology. 1982 Jul;144(1):109-13. doi: 10.1148/radiology.144.1.7089241.
9
Surveillance of bromocriptine in pregnancy.孕期溴隐亭的监测。
JAMA. 1982 Mar 19;247(11):1589-91.
10
Prolactin cells in the human pituitary. A quantitative immunocytochemical analysis.人类垂体中的催乳素细胞。定量免疫细胞化学分析。
Arch Pathol Lab Med. 1982 Jul;106(7):360-3.
Zotero 插件